Drug intelligence / Profile preview

xiao huo luo wan

Development stage
Unknown
Lead developer
Liaoning Jindan Pharmaceutical
Administration
Oral
01

Overview

Xiao Huo Luo Wan is a classic Traditional Chinese Medicine (TCM) formula manufactured by Liaoning Jindan Pharmaceutical. It is primarily indicated for the treatment of Wind-Cold-Dampness Bi-syndrome, which manifests as joint pain, muscle numbness, and limb stiffness, typically associated with conditions such as rheumatoid arthritis and osteoarthritis. The formula consists of six main ingredients: *Arisaema cum Bile* (胆南星), *Aconiti Kusnezoffii Radix Preparata* (制草乌), *Aconiti Radix Cocta* (制川乌), *Olibanum* (乳香), *Myrrha* (没药), and *Lumbricus* (地龙). These components work synergistically to dispel wind, remove dampness, transform phlegm, and unblock the collaterals. Pharmacologically, the preparation exhibits analgesic and anti-inflammatory properties, likely through the modulation of inflammatory cytokines and improvement of local microcirculation.

Brand names
Xiao Huo Luo Wan
Other names
Xiao Huo Luo PillsMinor Activating Channels PillsMinor Invigorate the Collaterals Pill

Beyond the preview

Go deeper on xiao huo luo wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiao huo luo wan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call